Acusensus Limited (ASX:ACE)
Australia · Delayed Price · Currency is AUD 1.280
+0.020 (1.59%)
Sep 8, 2026, 4:10 PM AEST
Acusensus Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 86.17 | 59.35 | 49.63 | 42.01 | 28.65 |
| 86.17 | 59.35 | 49.63 | 42.01 | 28.65 | |
Revenue Growth | 45.18% | 19.60% | 18.14% | 46.61% | 357.01% |
Cost of Revenue | 50.01 | 32.78 | 27.05 | 23.57 | 16.17 |
Gross Profit | 36.16 | 26.57 | 22.58 | 18.44 | 12.48 |
Selling, General & Admin | 28.93 | 22.3 | 17.46 | 12.74 | 8.11 |
Other Operating Expenses | 0.68 | 0.18 | 0.81 | -0.07 | -0.08 |
Operating Expenses | 41.28 | 29.71 | 24.57 | 17.36 | 11.22 |
Operating Income | -5.12 | -3.15 | -1.99 | 1.08 | 1.26 |
Interest Expense | -0.5 | -0.14 | -0.09 | -0.08 | -0.04 |
Interest & Investment Income | 0.63 | 1.01 | 0.92 | 0.26 | 0 |
Other Non Operating Income (Expenses) | 0 | 0.02 | 0.17 | -0.68 | -0.06 |
EBT Excluding Unusual Items | -5 | -2.26 | -1 | 0.58 | 1.16 |
Asset Writedown | -0.7 | -0.32 | -0.43 | -0.22 | - |
Legal Settlements | -18.74 | -0.76 | - | - | - |
Pretax Income | -24.11 | -3.33 | -1 | 0.58 | 1.16 |
Income Tax Expense | 0.18 | -0.7 | 0.52 | 0.52 | -0.26 |
Net Income | -24.29 | -2.62 | -1.52 | 0.06 | 1.43 |
Net Income to Common | -24.29 | -2.62 | -1.52 | 0.06 | 1.43 |
Net Income Growth | - | - | - | -96.14% | - |
Shares Outstanding (Basic) | 155 | 134 | 126 | 112 | 100 |
Shares Outstanding (Diluted) | 155 | 134 | 126 | 120 | 106 |
Shares Change | 15.77% | 5.90% | 5.24% | 12.95% | 59.09% |
EPS (Basic) | -0.16 | -0.02 | -0.01 | 0.00 | 0.01 |
EPS (Diluted) | -0.16 | -0.02 | -0.01 | 0.00 | 0.01 |
EPS Growth | - | - | - | -96.73% | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -19.5 | -4.99 | -1.99 | 0.28 | -1.85 |
Free Cash Flow Per Share | -0.13 | -0.04 | -0.02 | 0.00 | -0.02 |
Gross Margin | 41.96% | 44.76% | 45.50% | 43.90% | 43.57% |
Operating Margin | -5.94% | -5.30% | -4.02% | 2.58% | 4.40% |
Profit Margin | -28.19% | -4.42% | -3.07% | 0.13% | 4.98% |
Free Cash Flow Margin | -22.63% | -8.41% | -4.02% | 0.67% | -6.46% |
EBITDA | 1.2 | 0.39 | 1.8 | 3.86 | 3.07 |
EBITDA Margin | 1.39% | 0.66% | 3.62% | 9.19% | 10.73% |
D&A For EBITDA | 6.32 | 3.54 | 3.79 | 2.78 | 1.81 |
EBIT | -5.12 | -3.15 | -1.99 | 1.08 | 1.26 |
EBIT Margin | -5.94% | -5.30% | -4.02% | 2.58% | 4.40% |
Effective Tax Rate | - | - | - | 90.44% | - |